ADVFN Logo

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

NVS Novartis AG

96.30
0.37 (0.39%)
08 Dic 2023 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Novartis AG NVS NYSE Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.37 0.39% 96.30 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
96.11 95.95 96.445 96.30 95.93
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/12/202304:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
05/12/202323:18PRNUSNovartis receives FDA approval for Fabhalta® (iptacopan),..
05/12/202305:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
29/11/202305:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202314:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202305:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202301:12DJNNovartis Raises Mid-Term Sales Growth Targets
13/11/202308:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
01/11/202307:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202301:43DJNNovartis Skin Treatment Drug Cosentyx Gets US FDA Approval
30/10/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202302:07DJNNovartis to Seek US Accelerated Approval of Atrasentan After..
27/10/202300:45DJNNovartis Says FDA Deems Pluvicto Shortage Resolved, Supply..
24/10/202306:22IHMARKETNEWSTuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,..
24/10/202305:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202302:32DJNNovartis Raises Earnings Guidance Again After Key Drugs..
24/10/202300:48DJNNovartis Raises Earnings Guidance After Key Drugs Boost..
06/10/202316:11DJNNovartis Gets FDA Approval IV Formulation of Cosentyx
04/10/202305:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202304:17DJNNovartis Spinoff Sandoz Group Valued at $11.2 Billion in..
02/10/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202301:10DJNNovartis Says Kidney Drug Phase 3 Trial Reaches Positive..
26/9/202301:03DJNNovartis's Sandoz to Commercialize Multiple Sclerosis..
25/9/202306:17IHMARKETNEWSMonday’s Wall Street Highlights: Ford, Amazon, Paramount,..
25/9/202301:08DJNNovartis's Radioligand Therapy Shows Survival Improvement..
19/9/202315:08EDGAR2Form 144 - Report of proposed sale of securities
18/9/202301:16DJNNovartis Cancer Drug Gets Marketing Recommendation from..
15/9/202308:32IHMARKETNEWSFriday’s Wall Street Highlights: Ford Motor, Arm,..
15/9/202305:27DJNNovartis Shareholders Give Green Light to Sandoz Spinoff
11/9/202309:00PRNUSNovartis Issues Voluntary Nationwide Recall of One Lot of..
11/9/202306:58DJNBausch + Lomb Launches Proposed Financing for Xiidra..
11/9/202301:02DJNNovartis's Sandoz to Commercialize Autoimmune Disorders..
05/9/202305:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202308:05DJNNovartis's Leqvio Injection Effective at Reducing..
25/8/202307:50IHMARKETNEWSFriday’s Wall Street Highlights: Hawaiian Electric, Disney,..
25/8/202301:02DJNNovartis's Sandoz Gets FDA Approval for Multiple Sclerosis..
21/8/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202310:58DJNTrending: Novartis Set to Spin off Sandoz in October
18/8/202302:05DJNNovartis to Spin Off Sandoz in October -- Update
18/8/202301:14DJNNovartis Sets Sandoz Spinoff Date for Oct. 4
15/8/202301:11DJNNovartis Unit Sandoz Says Biosimilar Aflibercept Mylight..
09/8/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/8/202301:11DJNNovartis's Remibrutinib Trials For Chronic Urticaria Meet..
18/7/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/7/202306:27IHMARKETNEWSTuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
18/7/202301:00DJNNovartis Raises 2023 Guidance; Launches $15 Billion Buyback
17/7/202307:46DJNNovartis Buys DTx Pharma for $500 Million Plus Milestone..
17/7/202307:43DJNNovartis Buys DTx Pharma for $500 Million Plus Milestone..
17/7/202306:30IHMARKETNEWSMonday’s Wall Street Highlights: Microsoft, Santander,..
10/7/202315:08EDGAR2Form DFAN14A - Additional definitive proxy soliciting..

Su Consulta Reciente

Delayed Upgrade Clock

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

Support: (55) 4170 8128 | soporte@advfn.mx